文摘
Reducing host toxicity is one of the main challenges of cancer chemotherapy. Many tumor cells contain high levels of ROS that make them distinctively different from normal cells. We report a series of ROS-activated aromatic nitrogen mustards that selectively kill chronic lymphocytic leukemia (CLL) over normal lymphocytes. These agents showed powerful DNA cross-linking abilities when coupled with H<sub>2sub>O<sub>2sub>, one of the most common ROS in cancer cells, whereas little DNA cross-linking was detected without H<sub>2sub>O<sub>2sub>. Consistent with chemistry observation, in vitro cytotoxicity assay demonstrated that these agents induced 40鈥?0% apoptosis in primary leukemic lymphocytes isolated from CLL patients but less than 25% cell death to normal lymphocytes from healthy donors. The IC<sub>50sub> for the most potent compound (2) was 5 渭M in CLL cells, while the IC<sub>50sub> was not achieved in normal lymphocytes. Collectively, these data provide utility and selectivity of these agents that will inspire further and effective applications.